CPEX PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cpexpharm.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin
- First Posted Date
- 2009-02-24
- Last Posted Date
- 2016-02-15
- Lead Sponsor
- CPEX Pharmaceuticals Inc.
- Registration Number
- NCT00850161
Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus
Phase 2
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: NasulinOther: Placebo for Nasulin
- First Posted Date
- 2009-02-24
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- CPEX Pharmaceuticals Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT00850096
- Locations
- 🇺🇸
Radiant Research, Chandler, Arizona, United States
🇺🇸AMCR Institute, Inc, Escondido, California, United States
🇺🇸Scripps Whittier Diabetes Clinic, LaJolla, California, United States
News
No news found